Fetal growth and postnatal growth failure in very-low-birthweight infants

Kyla-Anna Marks1, Brian Reichman, Ayala Lusky

  • 1Department of Neonatal Medicine, Soroka University Medical Centre, PO Box 151, Beersheva, Israel. kamarks@bgu.ac.il

Insights

Severe postnatal growth failure (PNGF) affects 10.6% of very-low-birthweight (VLBW) infants. Both poor intrauterine growth and neonatal morbidities significantly increase the risk for PNGF in these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Pediatric Growth and Development
  • Perinatal Medicine

Background:

  • Postnatal growth failure (PNGF) is a significant concern in very-low-birthweight (VLBW) infants.
  • Understanding the factors contributing to PNGF is crucial for improving infant outcomes.

Purpose of the Study:

  • To determine the incidence of PNGF in VLBW infants.
  • To investigate the influence of intrauterine growth and neonatal morbidities on the risk of severe PNGF.

Main Methods:

  • Analysis of the Israel Neonatal Network database for VLBW infants born 1995-2001.
  • Calculation of Z-scores for birthweight (BW) and discharge weight.
  • Definition of severe PNGF as a Z-score decline >2; regression analysis for risk factors.

Main Results:

  • Severe PNGF occurred in 10.6% of VLBW infants.
  • Decreasing BW and gestational age were associated with increased PNGF incidence.
  • Neonatal morbidities including RDS, PDA, sepsis, NEC, and BPD were linked to severe PNGF.

Conclusions:

  • Intrauterine growth status significantly impacts postnatal growth in VLBW infants.
  • Major neonatal morbidities are key contributors to severe PNGF.
  • Birth growth status is an essential consideration when assessing postnatal growth in VLBW infants.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...